ELIAS Animal Health, LLC Email Format

Biotechnology ResearchKansas, United States11-50 Employees

ELIAS Animal Health is a medical biotechnology company focused on advancing a pipeline of immunotherapies, including an adoptive cell therapy and an oncolytic virotherapy, for the treatment of canine cancers. The company’s therapeutic pipeline offers the prospect of improved clinical outcomes and the potential for fundamentally changing the way cancer is treated. Learn more at www.eliasanimalhealth.com.

About ECI®
The company's lead product, ELIAS Cancer Immunotherapy (ECI®), is the first-ever USDA-approved treatment for canine osteosarcoma, a deadly form of bone cancer in dogs. combines an autologous vaccine with cell therapy to target a patient’s unique cancer cells. This personalized approach can improve clinical outcomes and provide a better quality of life for canine patients.

Learn more at eliasanimalhealth.com.

Sign up for free to view info

Company overview Employee directory